// App-Quantinova.ai

: Patient-Reported Treatment Satisfaction in Etripamil-Mediated Conversion of Supraventricular Tachycardia to Sinus Rhythm Results From the NODE-301 Study

Researchers

Presenter

  • James E Ip

Principal Investigators

  • Bruce S Stambler

  • Francis Plat

  • Benoit Coutu

  • Blandine Mondesert

  • Atul Verma

  • Silvia Shardonofsky

  • Alan J Camm

Medical Centers

  • Piedmont Heart Institute, Atlanta, GA

  • Partners in Advanced Cardiac Evaluation, Cardiology Clinic, Canada

  • Montreal Heart Institute, Universite Montreal, Montreal, QC, Canada

  • DalCor Pharmaceuticals, Montreal, Canada

  • Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY

  • Centre hospitalier de l’Université de Montréal, Montréal, ON, Canada

  • St George's, University of London, London, United Kingdom

Locations

  • United States

  • Canada

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Arrhythmia

Biomarkers

  • N/A

Drug/Treatment

  • Etripamil

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Controlled

Phase

  • III

Study Id's

  • NCT03464019

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved